Cargando…
Targeted Lung Cancer Treatments and Eye Metastasis
Lung cancer remains the leading cause of death due to cancer. We do not have effective tools for the early detection of lung cancer, so patients are usually diagnosed at an advanced stage. However, novel therapies based on molecular pathways (such as those involving the epidermal growth factor recep...
Autores principales: | ZAROGOULIDIS, Paul, BAKA, Sofia, LABAKI, Sofia, LAZARIDIS, George, TRAKADA, Georgia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medical Hypothesis, Discovery & Innovation Ophthalmology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392227/ https://www.ncbi.nlm.nih.gov/pubmed/28428969 |
Ejemplares similares
-
Lung Cancer and Eye Metastases
por: Lampaki, Sofia, et al.
Publicado: (2014) -
Tyrosine Kinase Inhibitors for Non-Small Cell Lung Cancer and Eye Metastasis: Disease Relapse or a New Entity?
por: ZAROGOULIDIS, Paul, et al.
Publicado: (2016) -
Progressive dyspnea due to pulmonary carcinoid tumorlets
por: Kallianos, Anastasios, et al.
Publicado: (2017) -
Could Somatostatin Enhance the Outcomes of Chemotherapeutic Treatment in SCLC?
por: Domvri, Kalliopi, et al.
Publicado: (2015) -
Defining the Role of Tyrosine Kinase Inhibitors in Early Stage Non-Small Cell Lung Cancer
por: Lampaki, Sofia, et al.
Publicado: (2015)